PeptideCalculations
GnRH-releasing neuropeptide · studied for LH, FSH and testosterone release, fertility research, sexual response (kisspeptin-54 studies)

Kisspeptin-10 dosage

Kisspeptin-10 is a 10-amino-acid peptide that tells the hypothalamus to release GnRH, which raises LH, FSH and testosterone. In men, IV boluses of 0.3 to 10 nmol/kg (roughly 30 to 900 mcg) raised LH within minutes; in women the response depends on cycle phase and subcutaneous boluses up to 32 nmol/kg did nothing in the follicular phase. There is no validated subcutaneous injection protocol. Community use is 100 to 200 mcg a few times a week, labeled by the people who publish it as an extrapolation.

0.3 nmol/kg to 10 nmol/kg IV bolus (about 30 mcg to 900 mcg at 70 kg)per dose

Basis: clinical trial (Jayasena, Dhillo et al. 2011, J Clin Endocrinol Metab, 11 men and 35 women). LH rose in men at every dose, maximal at 10 nmol/kg; in women only in the preovulatory phase

How often
2 to 3 times a week (community); continuous exposure blunts the LH response
When
morning or before training; some take it 1 to 2 hours before sex, copying kisspeptin-54 arousal studies
How long
4 to 8 weeks, then off; daily use risks desensitizing the response
Route
subcutaneous (community); intravenous in the published studies
Storage
lyophilized: freezer or fridge; reconstituted: fridge, use within 2 to 4 weeks (commonly reported)

Dose ranges by source

RangePerBasisNote
0.3 nmol/kg to 10 nmol/kg IV bolus (about 30 mcg to 900 mcg at 70 kg)doseclinical trial (Jayasena, Dhillo et al. 2011, J Clin Endocrinol Metab, 11 men and 35 women)LH rose in men at every dose, maximal at 10 nmol/kg; in women only in the preovulatory phase
2 nmol/kg to 32 nmol/kg subcutaneous bolusdoseclinical trial (Jayasena et al. 2011, women in the follicular phase)no LH or FSH change at any subcutaneous dose in that phase
100 mcg to 200 mcgdosecommonly reportedsubcutaneous, 2 to 3 times a week or every other day; not derived from a trial

Kisspeptin-10 dose to units chart

5 mg vial + 5 mL bacteriostatic water = 1 mg/mL (10 mcg per unit on a U-100 insulin syringe). 5 mg + 5 mL = 1 mg/mL, so 100 mcg = 0.1 mL = 10 units and 200 mcg = 20 units. A 10 mg vial + 5 mL is 2 mg/mL: 100 mcg = 5 units.

DosemLUnits (U-100)Doses per vial
0 mcg0.00030.0320000
0 mcg0.00030.0316666
2 mcg0.0020.22500
3 mcg0.00250.252000
5 mcg0.0050.51000
10 mcg0.011500

Different vial or water? Full 5 mg + 5 mL table or set your own numbers below.

mL
Draw to
—units
— mL on a U-100, 1 mL barrel
Concentration
—mg/mL
— mcg per unit
Doses in the vial
—
of

Side effects

Before you start. No validated subcutaneous dosing exists; the published human data is IV and a chronic subcutaneous infusion study in men. Anyone with hormone-sensitive cancer (prostate, breast), pregnancy, or on fertility treatment should not use it. Continuous dosing can shut the response down. Not medical advice. Talk to a clinician and start low.

Kisspeptin-10 dosage questions

Kisspeptin-10 dosage for testosterone?

Community use is 100 to 200 mcg subcutaneously two or three times a week. The human studies that raised testosterone used IV boluses of roughly 30 to 900 mcg or controlled subcutaneous infusions, not single shots, so the 100 to 200 mcg figure is an extrapolation. Start at 100 mcg.

How many units of kisspeptin is 100 mcg?

At 1 mg/mL (5 mg in 5 mL) 100 mcg is 10 units. With 2 mL of water it is 4 units, which is hard to measure, so use more water.

Can you take kisspeptin every day?

Better not. Continuous kisspeptin exposure makes the LH response fade (the 12-day infusion study saw gonadotropins return to baseline on continuous dosing). Two or three doses a week keeps the signal pulsatile.

Does kisspeptin work in women?

It depends on cycle phase. In the 2011 study kisspeptin-10 raised LH only in the preovulatory phase and did nothing, by any route, in the early follicular phase. Women using it for libido are copying kisspeptin-54 research, a different peptide.

Sources

  1. Jayasena CN, Nijher GMK, Comninos AN, Dhillo WS et al., J Clin Endocrinol Metab 2011, The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans (PMC3232613)
  2. Chronic subcutaneous kisspeptin-10 stimulates gonadotropin secretion for 12 days in healthy men, Eur J Endocrinol 2026 (DOI 10.1093/ejendo/lvag134)
  3. Peptide Dossier, Kisspeptin peptide research and dosage (community range labeled as extrapolation)

Brands we recommend for Kisspeptin-10. We are independent and have no affiliation with any brand: no affiliate links, no referral codes, no paid placements. These are the suppliers whose testing and certificates hold up when we check them.

This page is an educational summary of published labels, trials and commonly reported use. It is not medical advice and does not replace a clinician.